South Africa's Medicines Control Council will have to wait until the end of the year for a report from the United States which will guide its decision on whether to review the registration of nevirapine for the prevention of mother to child transmission (PMTCT) of HIV.
Links
[1] https://www.pambazuka.org/author/contributor
[2] https://www.pambazuka.org/taxonomy/term/3286
[3] https://www.pambazuka.org/article-issue/88
[4] https://www.pambazuka.org/taxonomy/term/3285
[5] http://www.pambazuka.org/en/category.php/hivaids/11356
[6] https://www.pambazuka.org/taxonomy/term/3287